Collagen-specific single-chain antibody, its coding gene and application
A specific binding, single-chain antibody technology, applied in the direction of antibodies, hybrid peptides, specific peptides, etc., can solve the problems of reducing the therapeutic effect of full-length antibodies, slow speed, insurmountable and other problems, and achieve the effect of good application prospects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0032] As mentioned above, in view of the many defects in the prior art, the inventors of this case have prepared a single-chain antibody (CBD-scFv) with collagen-specific binding through long-term research and a lot of practice. For example, the functional region of cetuximab is fused and expressed, and the yeast expression system is preferably used to successfully obtain the CBD-scFv fusion antibody fragment. The CBD-scFv has good collagen-specific binding ability in vitro and in vivo, and Maintaining the ability to bind to EGFR and anti-tumor activity, CBD-scFv can quickly accumulate at the site of tumor occurrence and play a killing role on tumor cells.
[0033] The technical solutions of the present invention will be described in more detail below in conjunction with the accompanying drawings and preferred embodiments.
[0034] 1. High-efficiency expression and purification of CBD-scFv in yeast
[0035] i, construction of CBD-scFv expression vector
[0036] V of CBD-scF...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com